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Abstract An actin-binding protein domain we call here 
'calponin-homology' or CH is present in signalling proteins such 
as Vav which are involved in activation and inactivation of small 
G-proteins. Using profile methods, we have detected two repeats 
of this domain in the actin-binding region of a-actinin and related 
proteins. Based on this, we propose that CH domain in Vav and 
other signalling proteins is employed for association with filamen- 
tous actin, and that this function correlates with their control on 
the G-proteins Rac and Rho which are involved in the organiza- 
tion of cytoskeleton. 
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proto-oncogene product Vav and two open reading frames 
which probably code for signalling proteins (human hsorfp_l 
and nematode cec35b8_2). The latter conclusion is based on the 
presence of other domains peculiar to signal-transducing pro- 
teins such as SH2, SH3, PH, DH and DAG/PE-binding do- 
mains (Fig. 1). Some of the previous statements [3,4] about 
similarities between calponins and other proteins pass our sta- 
tistical test after proper alignment. The N- and C-terminal 
boundaries of the CH domain are based on the examination of 
multiple alignment and on its terminal location in several pro- 
teins (Figs. 1 and 2). 
3. CH domain: putative function and predicted structure 
1. Introduction 
Calponins are an emerging family of proteins, mainly in- 
volved in the regulation of smooth muscle contraction. Their 
interaction with actin filaments is an essential condition for the 
regulation of the actin-myosin machinery [1,2]. Calponins con- 
sist of a unique N-terminal domain followed by one to three 
calponin repeats. It has been proposed that the N-terminal 
domain is homologous to the actin-binding domain of ~-actinin 
[1]. It has been further suggested that some members of the 
calponin family share sequence similarity with the N-terminal 
regions of Vav [3] and a human protein related to Ras-GAP 
[4]. However, these similarities have not been tested by meth- 
ods that can give statistical confidence on sequence homol- 
ogy. 
During the evolution of eukaryotes, domains carrying a dis- 
tinct function have been shuffled between otherwise unrelated 
proteins [5]. The N-terminal calponin domain ('calponin-ho- 
mology' or CH) appears to be such a protein module with a 
characteristic function. We define here the boundaries of the 
CH domain and demonstrate hat it is present in a number of 
different proteins. The common feature of these cytoskeletal 
and signalling proteins may be binding to F-actin. 
2. Database searches 
The database searches using the N-terminal calponin domain 
with a variety of methods resulted in significant matches (Fig. 
2) to sequences in other actin-binding proteins (see below), a 
Ras-GAP-related protein, a protein expressed in neurons, the 
*Corresponding author. Fax: (49) (6221) 387 306. 
The actin-binding domain of ~-actinin has approximately 
250 amino acid residues and is found in three protein families, 
namely in the spectrin family (which includes fl-spectrin, a- 
actinin, dystrophin and utrophin), the filamin family (including 
the actin gelation factor of Dictyostelium discoideum) and the 
fimbrin family [6]. These cytoskeletal proteins are known to 
cross-link actin filaments, binding to the same region of actin 
[7]. Sequence alignments and image reconstitution with electron 
microscopy have proposed that the actin-binding domain con- 
sists of two sub-domains with a similar size [8,9], and it has been 
shown that the N-terminal half alone is able to bind to F-actin 
[10]. Actin-binding residues (Fig. 2) have been mapped to both 
sub-domains [6,11]. Our sequence comparison further indicates 
that both share significant homology with the calponin domain. 
Thus, when the pieces of the puzzle are put together, CH 
emerges as the prototypic domain which can be assigned a 
potential actin-binding function. 
The structure of the CH domain is probably mainly a-helical 
as the structure predictions with the PHD program [12] propose 
four c~-helices. There is a tendency that the CH domain(s) is 
(are) located at the N-terminus of the host protein. The inde- 
pendent nature of the CH domain is demonstrated by a neu- 
ronal protein which appears to be exclusively made of this 
domain and by a protein of unknown function (cetl5bl2_l 
in Fig. 1) that contains a single CH domain which seems 
to be evolutionarily closely related to the second domain in ~- 
actinin. 
4. CH domain in signalling proteins 
The CH domain is present in a human Ras-GAP (GTPase- 
activating protein of Ras), proteins encoded by open reading 
frames called hsorfp_l and cec35b8_2, and in Vav. The three 
latter proteins contain the Dbl homology (DH) domain that is 
a guanine-nucleotide-exchange factor for small G-proteins 
0014-5793/95l$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI  0014-5793(95)01098-X 
150 J. Castresana, M. Saraste/FEBS Letters 374 (1995) 149 151 
calponin 
smooth muscle 
protein 
neuronal protein 
Vav 
cec35b8_2 
hsorfp_l 
Ras-GAP-like protein 
alpha-actinin 
filamin 
cetl5bl2_l  
° .  
°AP I 
x6 x4 
M calponin repeat 
DAG/PE-binding domain 
~]~ Ras-GAP-like protein 
N-terminal repeat 
[~ IQ motif 
Q spectrin repeat 
( ~  EF-hands 
I I ~'sheet repeat 
sm2h L E Q Illll Q~ T T Q C 
neurprot Q M R E E K E L E H L R 
vav LWRQCTHI I  I QCR 
hsorfp E E Q~V T~ I S L G 
cec35b8 L W I G C A R~ R D M K 
rasgap H L E E A K Rim E A C L 
a-actininl Q R K T~T A~ N S H L 
filaminl Q Q N T~T R~ N E H L 
a-actinin2 A K E G~L L~ Q R K T 
fi lamin2 PKQR~LG~ IQ NKL 
cetl5bl2 I K D A~L R~ IQ N R V 
calponin Q NW H Q~E~S 
sm2h i i i i [ i lAST  AFKQmE~S 
neurprot . . . .  PAVPKL  SMAKCRR~E 
. . . . . . . . .  RpQM SQ~T CmK~R 
hsorfp . . . . . . . . .  Q T E A D CgN~N 
cec35b8 . . . . . .  T N Q P S P F L C C N~N 
rasgap R E Q T R Y K A T G L H F R H T D IN  I 
a-actininl 
filaminl i [ i i [ i [ [ P 'P M R V H K~S~N FRQMQ~E~S 
a-actinin2 . . . . . . . . . . .  K D D P~T~N 
fi lamin2 . . . . . . . . . . .  A S K P IT~A,R  
cetl5bl2 . . . . . . . . . . .  P N N R R Y~D 
GLS I  . . . . . . . . . .  GP~ 
RKDVGRP QPG . . . .  RE~ 
ES IEMRL KVSL . . .HE~ 
VLPPSHR VTWDGAQ~CE 
VLESPKK T ICDP. .EEF  
VLTTDKN GT . . . . .  ~LE  
GEDLPP  . . . . . . . .  TTE  
KCVSKR . . . . . . .  
APYKNVN . . . . . .  
PQLP  . . . . . . . . .  
AGYPNVN . . . . . .  
N ~KAMVSYG 
Q QAAERYG 
N EACRKLG 
T STCCEKF  
D KGCAT. .  
Y AMFCKTYF  
Q ~NAMDEIG 
K DF IASK.  
V EFLDRE 
T DVAEKYL  
E QQADDWL 
L KVAEDN 
+++lilHll++++ i+ K R,+, EEG K F S 
E E D ~ K  mM'~EVlSG 
Q T D m ~ R  l !AmmE VmSQ 
ISW~C ~ a ~ R H R  m 
R DW~SS~A mmGA~S CA lm 
++ s w AmmmA ~un.  RIAIm 
il I NT  V ~ G K  VPEE~mCLP H ~ E K  GLKRSE~EA ~ V O  .~e V E~D e ~YSGV NLEDAD~TA ~ Y Y M N  LPK IFYPET  ~ R K  
G~'~iK L V S~G A ~ G  N V K 
S~KLVSmDS ~ M ~ M  GN LK  D PKM~D.A ~ . ~ T  A R P D 
G PQV~T . P ~ P N  . VD 
G FPL~EVD GDRPD 
GS~PKINRSM 
RS AS IHVPS 
HA NLREVNL 
GS EKFCLDP 
NG DQKKIMR 
KV SLKK IYD 
ER AKPERGK 
K RKHNQR 
E DYGKLR 
GLCPDWDSWD 
NS~.DFSKLD 
~qQ/A i l  A c_ IQ~Nm 
v ~ ~ Q  A l 
G ~ Y ~ A M  
s~s~mAZ 
Q~ImmK~ s Pm 
P~C~Y C~H A~ 
MT~G~I  ST  I~  
L I~G~I  W T L~ 
E IA~YBS s 
E H S ~ Y ~ S  Q 
wmc~YIQ s 
Fig. 2. Multiple alignment of CH domains. The actin-binding regions mapped by Winder et al. [11] are double-underlined. There is an obvious 
consistency in the alignments within calponin family and within the first and second sub-domains of the actin-binding domain in the spectrin/~-actinin 
family. In order to test whether the three sets of sequences (the calponin domain and the two sub-domains of spectrin/c~-actinin) are homologous 
to each other, we submitted the single-underlined 26 amino acid motifs (with no gaps) of the three subfamilies to independent searches in protein 
databases using the MoST program [18]. Each separate block identified the members of the two other subfamilies with r < 0.005, where r is the ratio 
of the expected number of sequence segments with a given score to the observed number. With profile methods based on the full alignment (using 
the PROFILESEARCH program [19]), independent profile searches using the first half of the spectrin/c~-actinin domain found calponins as the best 
matches after the proteins in the spectrin family. The same happened with profile searches using the second half of the spectrin/c~-actinin domain, 
and with calponin profiles which identified the members of the spectrin/~-actinin proteins next after calponins. The domains in signalling proteins 
were found during these searches. They gave the highest scores with calponin profiles. The multiple alignment was constructed with the CLUSTALW 
program [20] and manually refined. Positions with conserved residues in 50% or more of the sequences are shadowed. Light shadowing for similar 
amino acids is applied according to the Gonnet matrix [21] of amino acid substitutions (only values greater than 1.5 are considered for shadowing). 
Identification names for the sequences containing the CH domain (with the position of the domain) are calponin, CLP2_MOUSE (29 127), sm2h, 
SM2H_HUMAN (26-132), neurprot, NEUR_FELCA (3 113), vav, VAV HUMAN (3-115), ~-actinin, AACI_HUMAN (33 131 and 146-244) and 
filamin, ABP2_HUMAN (45-145 and 168 263) in the SWISSPROT database, and hsorfp, HSORFP (first off, 1 103), cec35b8, CEC35B8 (second 
off, 7 114), ras-GAP, HSIQGA (first orf, 46-155) and cetl5bl2, CETI5B12 (first orf, 115-213) in the EMBL database. All seqeuces are from human 
exept CLP2_MOUSE from mouse, NEUR_FELCA from cat and CEC35B8 and CET15B12 from Caenorhabditis elegans. We have become aware 
that the CH domain has also been discovered by Philipp Bucher and Kay Hofmann (Swiss Institute of Experimental Cancer Research, Lausanne) 
in a similar search. They have submitted a profile to the PROSITE database under accession umber PS50021. 
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Fig. 1. Molecular architecture ofproteins containing the CH domain. 
The symbols for different domains are given on the right. A figure 
below a domain indicates the number of tandem repeats. The domains 
in open reading frames hsorfp_l, cec35b8 2 and cetl5bl2_l were iden- 
tified with BLAST [17]. See legend to Fig. 2 for entry names. 
4-- 
(Ras, Rho and Rac; see ref. [13]). The proto-oncogene product 
Vav is a complex modular protein that is specifically expressed 
in haematopoietic cells. It is interesting that cec35b8_2, a pro- 
tein with a similar domain composition to Vav (Fig. 1), is 
present in nematodes which have no circulatory system. The 
N-terminus of Vav has been proposed to contain a helix-loop- 
helix DNA-binding domain, but our data based on profile 
methods clearly show that it has a CH domain. This is probab- 
ly the last domain of Vav that has remained to be assigned 
(Fig. 1). Vav is known to become oncogenic when its first 
65 N- terminal amino acids are deleted [14,15]. The actin-bind- 
ing CH domain of Vav is therefore ssential for normal func- 
tion. 
It is well established that cytoskeletal proteins uch as spec- 
trin share domains with signalling proteins [16]. The novel pic- 
ture that now emerges hows the converse: signalling proteins 
may contain functional domains that have until now been 
found only in cytoskeletal proteins. The four examples discov- 
ered by our search have a domain that may be involved in 
binding to actin filaments. In particular, this could be required 
for the correct localization of factors activating or inactivating 
small G-proteins uch as Rho and Rac that are involved in the 
organization of cytoskeleton and in cellular processes uch as 
membrane ruffling [13]. 
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